EDGAR Filing Documents for 0000950123-13-010182

Form DRS - Draft Registration Statement:

SEC Accession No. 0000950123-13-010182

Filing Date

2013-12-04

Accepted

2013-12-04 16:56:23

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.htm	DRS	2035198
2		filename2.htm	EX-3	82089
3		filename3.htm	EX-3	78802
4		filename4.htm	EX-3	24022
5		filename5.htm	EX-4	157363
6		filename6.htm	EX-10	19855
7		filename7.htm	EX-10	20300
8		filename8.htm	EX-10	178963
9		filename9.htm	EX-10	177255
10		filename10.htm	EX-10	149084
11		filename11.htm	EX-10	26249
12		filename12.htm	EX-10	19681
13	GRAPHIC	g636936exg_pg001.jpg	GRAPHIC	12090
14	GRAPHIC	g615506g57i48.jpg	GRAPHIC	25028
15	GRAPHIC	g636936exf_pg001.jpg	GRAPHIC	12988
	Complete submission text file	0000950123-13-010182.txt		3039461

Mailing Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803

Business Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803 617-513-9882

Aldexa Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)